Immunome posts corporate presentation on website for investor meetings

Immunome Inc.

Posted presentation dated January 2023 under Item 8.01 of Form 8-K.
Presentation may be used in meetings with investors, analysts, collaborators, vendors.
Presentation attached as Exhibit 99.1 and incorporated by reference into Item 8.01.
Report signed by President and CEO Purnanand D. Sarma on January 30, 2023.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.